S. 3094 - PRICED Act
- Sponsor:
- Sherrod Brown
- Summary:
- A bill to amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years. (by CRS)
- Status:
- The bill has been referred to committee.
PRICED Act
S. 3094 — 114th Congress (2015–2016)
- Summary
- A bill to amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years.
- Other Titles
- Price Relief, Innovation, and Competition for Essential Drugs Act
- PRICED Act
- PRICED Act
- Sponsor
- Sherrod Brown
- Co-Sponsors
- Subjects
- Health
- Drug safety, medical device, and laboratory regulation
- Licensing and registrations
- Marketing and advertising
- Related Bills
- Major Actions
Introduced 6/23/2016 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 6/23/2016 6/23/2016 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. 6/23/2016 Introduced in Senate Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
Contributions data source: OpenSecrets.org